Melanotan I
Afamelanotide — UV-Independent Tanning Research
Melanotan I (afamelanotide) is a synthetic analogue of alpha-MSH that selectively activates MC1R — the melanocortin receptor responsible for eumelanin production in melanocytes. Unlike Melanotan II, it doesn't activate MC3R/MC4R, giving it a cleaner, photoprotection-focused profile without the sexual arousal or appetite effects of its analogue.
At a Glance
MC1R activation drives melanocytes to produce eumelanin — the dark, UV-absorbing pigment that provides natural photoprotection. Melanotan I achieves melanogenesis without UV exposure, which has made it medically relevant for conditions where sun exposure triggers dangerous reactions.
FDA approval (as Scenesse) for erythropoietic protoporphyria (EPP) — a condition where sun exposure causes severe pain — validated the MC1R mechanism for photoprotection beyond cosmetic applications.
Research interest extends to its potential in skin cancer prevention, photosensitivity disorders beyond EPP, and as a comparator to Melanotan II for isolating MC1R-specific effects from the broader melanocortin cascade.
This compound operates through several converging biological pathways, which helps explain the breadth of effects observed across different tissue and metabolic models.
MC1R Selective Agonism
Selectively activates melanocortin 1 receptor on melanocytes — driving eumelanin synthesis without meaningful MC3R/MC4R activation.
Eumelanin Production
Stimulates the switch from phaeomelanin to eumelanin — the darker, UV-protective pigment that provides natural photoprotection.
UV-Independent Photoprotection
Increases melanin density before UV exposure — providing pre-emptive photoprotection for conditions requiring sun avoidance.
EPP Photoprotection
Reduces the phototoxic skin reactions in erythropoietic protoporphyria — the validated clinical indication driving FDA approval.
Preclinical and clinical models have investigated this compound across a wide range of physiological contexts and tissue types.
- Erythropoietic protoporphyria — FDA-approved indication for photoprotection
- Photoprotection and skin cancer prevention research — UV-independent melanin induction
- MC1R pathway characterization — selective vs non-selective melanocortin agonist comparison
- Polymorphic light eruption and solar urticaria — photosensitivity condition research
- Skin tanning mechanism — eumelanin vs phaeomelanin production and UV protection
- Comparison with Melanotan II — MC1R selectivity vs broad melanocortin agonism
- Melanoma biology — MC1R variants and melanoma risk research
Melanotan I's FDA approval and MC1R selectivity make it the reference compound for photoprotection and melanogenesis research.
Melanotan I vs II defines the selectivity spectrum of melanocortin research — selective MC1R photoprotection vs broad-spectrum CNS and melanogenesis activation.
| Aspect | Melanotan I | Melanotan II | Alpha-MSH (native) |
|---|---|---|---|
| Receptor Selectivity | MC1R selective | MC1R, MC3R, MC4R, MC5R | All MCR subtypes |
| Tanning Effect | Yes — eumelanin | Yes — eumelanin | Yes — eumelanin |
| Sexual Arousal | None | Significant | None at physiological levels |
| FDA Status | Approved — Scenesse (EPP) | Not approved | Endogenous — not a drug |
| Primary Research Use | Photoprotection, EPP | Tanning + sexual function | Mechanistic baseline |
The following reflects findings from published preclinical and clinical safety assessments where available.
FDA approved for EPP — validated clinical mechanism with Phase 3 data
MC1R selective — no CNS arousal or appetite effects; cleaner research profile for photoprotection studies
Pre-emptive photoprotection mechanism — unique among photoprotection research approaches
Subdermal implant delivery in approved form — not injectable in the traditional sense; research SC protocols differ from approved route
This overview is strictly educational and based on publicly available scientific literature as of 2026. It does not constitute medical advice. All Helixera Labs products are for laboratory research use only. Not for human or veterinary use. · Helixera Labs LLC © 2026